- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00409422
Effects of a Comprehensive Weight Management Program on Obese Adolescents and Children
June 20, 2008 updated by: Yale University
To compare anthropometric and metabolic effects of a comprehensive weight management program on obese adolescents and children in comparison to regular clinical weight management visits.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Patients are randomized (2:1) to either the intensive or standard treatment (control).
Those who get randomized into the intensive group go to a family-based weight management program, including exercise, nutrition, behavior modification, and parenting classes.
The intensive group is further randomized into a diet or non-dieting class to compare the outcomes of two different nutrition intervention methods.
These classes meet twice per week (exercise twice per week and nutrition/behavior modification once per week)for first six months and then only twice per month during last six months.
An exercise physiologist supervises the exercise component, which involves 45 minutes of aerobic activity (targeted at 65 to 80 percent of the subject's estimated maximum heart rate.
A registered dietitian facilitates the nutrition and behavior component.
A social worker facilitates parent classes when the children have a behavior modification topic in their class (parents only attend nutrition sessions).
Those who get randomized into the control group go to clinic visits every 6 months.
Intervention subjects go to clinic, as well, every 6 months to obtain the same measurements as the controls (weight, BMI, % fat, fasting insulin, fasting glucose, lipids, blood pressure).
Study Type
Interventional
Enrollment
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06520
- Yale University School Of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 16 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Ages 8-16 years old
- BMI >95th percentile for age/gender based on CDC
- Both primary caregiver/parent and child must agree to participate in the nutrition classes
Exclusion Criteria:
- endocrinopathies, including hypothyroidism and diabetes
- Psychiatric disorders that will interfere with ability to complete follow-up and adherence to protocol
- Any behavioral or psychosocial issue that will interfere with subject's completion of program, including eating disorder.
- Any use of medication (steroids, for ex.) that contributes to excess adiposity.
- Any use of pharmacological intervention for weight management, including prescription medications, over-the-counter medications, or herbal supplements.
- Any concurrent membership in a weight management program.
- Inability or unwillingness of parent to accompany the child to nutrition classes.
- Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
weight
Time Frame: 6 months and 1 year
|
6 months and 1 year
|
body mass index
Time Frame: 6 months and 1 year
|
6 months and 1 year
|
% body fat
Time Frame: 6 months and 1 year
|
6 months and 1 year
|
lipids
Time Frame: 6 months and 1 year
|
6 months and 1 year
|
blood pressure
Time Frame: 6 months and 1 year
|
6 months and 1 year
|
glucose
Time Frame: 6 months and 1 year
|
6 months and 1 year
|
insulin
Time Frame: 6 months and 1 year
|
6 months and 1 year
|
HOMA index
Time Frame: 6 months and 1 year
|
6 months and 1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
planned to compare dieting with non-dieting approach in weight management group
Time Frame: 6 months and 1 year
|
6 months and 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sonia Caprio, MD, Yale University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2002
Primary Completion (Actual)
October 1, 2006
Study Completion (Actual)
February 1, 2007
Study Registration Dates
First Submitted
December 6, 2006
First Submitted That Met QC Criteria
December 6, 2006
First Posted (Estimate)
December 8, 2006
Study Record Updates
Last Update Posted (Estimate)
June 24, 2008
Last Update Submitted That Met QC Criteria
June 20, 2008
Last Verified
June 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HIC 15994
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insulin Resistance
-
Washington University School of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedEndoplasmic Reticulum Stress | HIV Related Insulin Resistance | Protease Inhibitor Related Insulin ResistanceUnited States
-
Paloma Almeda-ValdésCompleted
-
German Diabetes CenterYale UniversityRecruiting
-
National Institute of Diabetes and Digestive and...Active, not recruitingSevere Insulin ResistanceUnited States
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
Assiut UniversityCompleted
-
National Taiwan UniversityNational Cheng-Kung University HospitalCompletedExercise, Insulin Resistance, Visceral Adipose TissueTaiwan
-
University Health Network, TorontoCompletedInsulin Resistance Syndrome X | Pancreatic Beta Cell FunctionCanada
-
The University of Texas Medical Branch, GalvestonCompletedInsulin Resistance, DiabetesUnited States
-
University Health Network, TorontoCompletedInsulin Resistance, DiabetesCanada
Clinical Trials on weight management program
-
University of OttawaThe Ottawa Hospital; Ontario Lung AssociationCompletedObesity | Metabolic SyndromeCanada
-
University of LeedsCompletedObesity | Overweight | Sedentary LifestlyeUnited Kingdom
-
ReShape LifesciencesActive, not recruitingObesity, MorbidUnited States
-
Société des Produits Nestlé (SPN)Completed
-
Jeannine Goetz, PhDCompletedWeight LossUnited States
-
State University of New York at BuffaloNational Center for Advancing Translational Sciences (NCATS)CompletedPsychotic Disorders | Diet, HealthyUnited States
-
Brigham and Women's HospitalPatient-Centered Outcomes Research InstituteCompleted
-
University of MelbourneNational Health and Medical Research Council, AustraliaCompletedOsteoarthritis | Overweight and ObesityAustralia
-
University of South CarolinaNational Institute on Aging (NIA)Recruiting
-
Robert Wood Johnson FoundationCompleted